The In Vivo and In Vitro Assessment of Pyocins in Treating <i>Pseudomonas aeruginosa</i> Infections
<i>Pseudomonas aeruginosa</i> can cause several life-threatening infections among immunocompromised patients (e.g., cystic fibrosis) due to its ability to adapt and develop resistance to several antibiotics. In recent years, <i>P. aeruginosa</i> infections has become difficul...
Main Authors: | Abdulaziz Alqahtani, Jonathan Kopel, Abdul Hamood |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/11/10/1366 |
Similar Items
-
Pseudomonas Aeruginosa Oligoribonuclease contributes to tolerance to ciprofloxacin by regulating pyocin biosynthesis
by: Chen, Fei, et al.
Published: (2018) -
Competition in Biofilms between Cystic Fibrosis Isolates of <italic toggle="yes">Pseudomonas aeruginosa</italic> Is Shaped by R-Pyocins
by: Olubukola Oluyombo, et al.
Published: (2019-02-01) -
High prevalence of lipopolysaccharide mutants and R2-pyocin susceptible variants in Pseudomonas aeruginosa populations sourced from cystic fibrosis lung infections
by: Madeline Mei, et al.
Published: (2023-12-01) -
Parallel Evolution to Elucidate the Contributions of PA0625 and <i>parE</i> to Ciprofloxacin Sensitivity in <i>Pseudomonas aeruginosa</i>
by: Qi Liu, et al.
Published: (2022-12-01) -
Bacterial Competition Systems Share a Domain Required for Inner Membrane Transport of the Bacteriocin Pyocin G from Pseudomonas aeruginosa
by: Iva Atanaskovic, et al.
Published: (2022-04-01)